-
1دورية أكاديمية
المؤلفون: Conte P., Frassoldati A., Bisagni G., Brandes A. A., Donadio M., Garrone O., Piacentini F., Cavanna L., Giotta F., Aieta M., Gebbia V., Molino A., Musolino A., Ferro A., Maltoni R., Danese S., Zamagni C., Rimanti A., Cagossi K., Russo A., Pronzato P., Giovanardi F., Moretti G., Lombardo L., Schirone A., Beano A., Amaducci L., Bajardi E. A., Vicini R., Balduzzi S., D'Amico R., Guarneri V.
المساهمون: Conte P., Frassoldati A., Bisagni G., Brandes A.A., Donadio M., Garrone O., Piacentini F., Cavanna L., Giotta F., Aieta M., Gebbia V., Molino A., Musolino A., Ferro A., Maltoni R., Danese S., Zamagni C., Rimanti A., Cagossi K., Russo A., Pronzato P., Giovanardi F., Moretti G., Lombardo L., Schirone A., Beano A., Amaducci L., Bajardi E.A., Vicini R., Balduzzi S., D'Amico R., Guarneri V.
مصطلحات موضوعية: Adjuvant, Breast cancer, Cardiac safety, De-escalated treatment, Trastuzumab, Adult, Aged, Anthracycline, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocol, Breast Neoplasm, Bridged-Ring Compound, Cardiotoxicity, Chemotherapy, Disease-Free Survival, Drug Administration Schedule, Female, Human, Mastectomy, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Receptor, ErbB-2, Taxoid, Time Factor, Settore MED/06 - Oncologia Medica
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30219886; info:eu-repo/semantics/altIdentifier/wos/WOS:000456859200012; volume:29; issue:12; firstpage:2328; lastpage:2333; numberofpages:6; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/10447/412769Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85059263988
-
2دورية أكاديمية
المؤلفون: Conte, P, Frassoldati, A, Bisagni, G, Brandes, A A, Donadio, M, Garrone, O, Piacentini, F, Cavanna, L, Giotta, F, Aieta, M, Gebbia, V, Molino, A, Musolino, A, Ferro, A, Maltoni, R, Danese, S, Zamagni, C, Rimanti, A, Cagossi, K, Russo, A, Pronzato, P, Giovanardi, F, Moretti, G, Lombardo, L, Schirone, A, Beano, A, Amaducci, L, Bajardi, E A, Vicini, R, Balduzzi, S, D'Amico, R, Guarneri, V
المساهمون: Conte, P, Frassoldati, A, Bisagni, G, Brandes, A A, Donadio, M, Garrone, O, Piacentini, F, Cavanna, L, Giotta, F, Aieta, M, Gebbia, V, Molino, A, Musolino, A, Ferro, A, Maltoni, R, Danese, S, Zamagni, C, Rimanti, A, Cagossi, K, Russo, A, Pronzato, P, Giovanardi, F, Moretti, G, Lombardo, L, Schirone, A, Beano, A, Amaducci, L, Bajardi, E A, Vicini, R, Balduzzi, S, D'Amico, R, Guarneri, V
مصطلحات موضوعية: trastuzumab, adjuvant, breast cancer, cardiac safety, de-escalated treatment
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30219886; info:eu-repo/semantics/altIdentifier/wos/WOS:000456859200012; volume:29; issue:12; firstpage:2328; lastpage:2333; numberofpages:6; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/11577/3283884Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85059263988; https://www.annalsofoncology.org/article/S0923-7534Test(19)34231-0/fulltext
الإتاحة: https://doi.org/10.1093/annonc/mdy414Test
http://hdl.handle.net/11577/3283884Test
https://www.annalsofoncology.org/article/S0923-7534Test(19)34231-0/fulltext -
3
المؤلفون: Conte, P., Frassoldati, A., Bisagni, G., Brandes, A. A., Donadio, M., Garrone, O., Piacentini, F., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Molino, A., Musolino, A., Ferro, A., Maltoni, R., Danese, S., Zamagni, C., Rimanti, A., Cagossi, K., Russo, A., Pronzato, P., Giovanardi, F., Moretti, G., Lombardo, L., Schirone, A., Beano, A., Amaducci, L., Bajardi, E. A., Vicini, R., Balduzzi, S., D'Amico, R., Guarneri, Falci C, V., Giarratano, T, Mcmahon, L, De Salvo GL, Dieci, Mv, Maiorana, A, Ficarra, G, Caggia, F, Grisolia, D, Bartolini, S, Lorusso, V, Ardito, R, Tartarone, A, Vanella, P, Taverniti, C, Porpiglia, M, Spanu, Pg, Biglia, N, Andreis, D, Piancastelli, A, Fedeli, A, Parra, Hs, Gambaro, Ar, Romito, S, Malossi, A, Gori, S, Miglietta, L, Del Mastro, L, Amoroso, D, Mansutti, M, Generali, D, Prati, G, Bertolini, A, Berardi, R, Zanni, A, Cottafavi, L, Bologna, A, Naso, G, Pancotti, A, Farci, D, Zoboli, A, Silva, R, Laudadio, L, Bordonaro, R, Marenco, D, Dongiovanni, V, Baldini, E, Saggia, C, Gorzegno, G, Cariello, A, Biganzoli, L, Rampello, E.
المساهمون: Conte P., Frassoldati A., Bisagni G., Brandes A.A., Donadio M., Garrone O., Piacentini F., Cavanna L., Giotta F., Aieta M., Gebbia V., Molino A., Musolino A., Ferro A., Maltoni R., Danese S., Zamagni C., Rimanti A., Cagossi K., Russo A., Pronzato P., Giovanardi F., Moretti G., Lombardo L., Schirone A., Beano A., Amaducci L., Bajardi E.A., Vicini R., Balduzzi S., D'Amico R., Guarneri V.
المصدر: Annals of Oncology. 29:2328-2333
مصطلحات موضوعية: Oncology, Time Factors, Adjuvant, Breast cancer, Cardiac safety, De-escalated treatment, Trastuzumab, Settore MED/06 - Oncologia Medica, Receptor, ErbB-2, medicine.medical_treatment, Anthracycline, 030204 cardiovascular system & hematology, Breast cancer, Antineoplastic Agents, Immunological, ErbB-2, 0302 clinical medicine, Trastuzumab, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Anthracyclines, skin and connective tissue diseases, Adjuvant, Mastectomy, Cardiac safety, De-escalated treatment, Hazard ratio, Hematology, Middle Aged, Chemotherapy regimen, Bridged-Ring Compound, Immunological, Local, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Taxoids, Trastuzumab, adjuvant, breast cancer, cardiac safety, de-escalated treatment, Breast Neoplasm, Human, Receptor, medicine.drug, Adult, Bridged-Ring Compounds, medicine.medical_specialty, Time Factor, Socio-culturale, Breast Neoplasms, Antineoplastic Agents, Disease-Free Survival, Drug Administration Schedule, 03 medical and health sciences, Taxoid, Internal medicine, medicine, Humans, Chemotherapy, Risk factor, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocol, business.industry, medicine.disease, Cardiotoxicity, Neoplasm Recurrence, Neoplasm Recurrence, Local, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61f781b7e9350a5669985b12e94ae5cTest
https://doi.org/10.1093/annonc/mdy414Test
